Identification of N-homocysteinylated apolipoprotein AI in normal human serum

Annals of Clinical Biochemistry

Volumn 47, Issue 5, 2010, Pages 453-459

  Ishimine, N ^a,b   Usami, Y ^a   Nogi, S ^a   Sumida, T ^a   Kurihara, Y ^a   Matsuda, K ^b   Nakamura, K ^c   Yamauchi, K ^d   Okumura, N ^e   Tozuka, M ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b SHINSHU UNIVERSITY HOSPITAL   (Japan)

^c UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

^e SHINSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; APOLIPOPROTEIN A1; HOMOCYSTEINE; MERCAPTAMINE; N HOMOCYSTEINYLATED APOLIPOPROTEIN A1; THIOL GROUP; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; CORRELATION ANALYSIS; HUMAN; ISOELECTRIC FOCUSING; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; REPRODUCIBILITY;

APOLIPOPROTEIN A-I; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; HOMOCYSTEINE; HUMANS; LIPOPROTEINS, HDL;

EID: 77957683266     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2010.010035     Document Type: Article

References (31)

1. Wilcken DE, Wilcken B. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest 1976;57:1079-83
2. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Ann Rev Med 1998;49:31-62
3. Handy DE, Zhang Y, Loscalzo J. Homocysteine down-regulates cellular glutathione peroxidase (GPx1) by decreasing translation. J Biol Chem 2005;280:15518-25
4. Lentz SR. Does homocysteine promote atherosclerosis? Arterioscler Thromb Vasc Biol 2001;22:1385-6
5. Tsai JC, Perrella M, Yoshizumi M, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA 1994;91:6369-73 (Pubitemid 24200662)
6. Wang G, Siow YLOK. Homocysteine stimulates nuclear factor kappaB activityand monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C. Biochem J 2000;352:817-26
7. Cattaneo M. Hyperhomocysteinemia and thrombosis. Lipids 2001;36(Suppl.):S13-26
8. Mikaei LG, Genest J Jr, Rozen R. Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease. Cir Res 2006;98:564-71
9. Liao D, Tan H, Hui R, et al. Hyperhomocysteinemia decreases circulating HDL by inhibiting apoA-I protein synthesis and enhancing HDL-C clearance. Cir Res 2006;99:598-606
10. Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004;291:565-75. See http://www.ncbi.nlm.nih. gov/pubmed/14762035?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed. Pubmed-ResultsPanel.Pubmed- DefaultReportPanel.Pubmed-RVDocSum (last checked June 2009)
11. Lonn E, Yusuf S, Arnold MJ, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006;354:1567-77. See http://www.ncbi.nlm.nih.gov/pubmed/16531613?ordinalpos=14&itool= EntrezSystem2.PEntrez.Pubmed.Pubmed-ResultsPanel.Pubmed-DefaultReportPanel. Pubmed-RVDocSum (last checked June 2009)
12. Bønaa KH, Njølstad I, Ueland PM, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006;354:1578-88. See http://www.ncbi.nlm.nih.gov/pubmed/16531614? ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed-ResultsPanel. Pubmed-DefaultReportPanel.Pubmed- RVDocSum (last checked June 2009)
13. Jakubowski H. Metabolism of homocysteine thiolactone in human cell cultures. Possible mechanism for pathological consequences of elevated homocysteine levels. J Biol Chem 1997;272:1935-42 (Pubitemid 27043288)
14. Jakubowski H. Molecular basis of homocysteine toxicity in humans. Cell Mol Life Sci 2004;61:470-87 (Pubitemid 38316582)
15. Jakubowski H. Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels. FASEB J 1999;13:2277-83
16. Jakubowski H, Zhang L, Bardeguez A, Aviv A. Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implication for atherosclerosis. Circ Res 2000;87:45-51 (Pubitemid 30456934)
17. Perla-Kajan J, Stanger O, Luczak M, et al. Immunohistochemical detection of N-homocysteinylated proteins in humans and mice. Biomed Pharmacother 2008;62:473-9
18. Undas A, Perla J, Lacinski M, Trzeciak W, Kazmierski R, Jakubowski H. Autoantibodies against N-homocysteinylated proteins in humans: implications for atherosclerosis. Stroke 2004;35:1299-304 (Pubitemid 38697447)
19. Jakubowski H. New method for the determination of protein N-linked homocysteine. Anal Biochem 2008;380:257-61
20. Uji U, Motomiya Y, Hanyu N, Ukaji F, Okabe H. Protein-bound homocystamide measured in human plasma by HPLC. Clin Chem 2002;48:941-4 (Pubitemid 34587598)
21. Perna AF, Satta E, Acanfora F, Lombardi C, Ingrosso D, De Santo NG. Increased plasma protein homocysteinylation in hemodialysis patients. Kidney Int 2006;69:869-76 (Pubitemid 43297898)
22. Yang X, Gao Y, Zhou J, et al. Plasma homocysteine thiolactone adducts associated with risk of coronary heart disease. Clin Chim Acta 2006;364:230-4
23. Glomset JA. The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res 1968;9:155-67
24. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-53
25. Jakubowski H. Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels. FASEB J 1999;13:2277-83
26. Jakubowski H. The determination of homocysteine-thiolactone in biological samples. Anal Biochem 2002;308:112-19
27. Chwatko G, Jakubowski H. The determination of homocysteine-thiolactone in human plasma. Anal Biochem 2005;337:271-7
28. Sass JO, Nakanishi T, Sato T, Sperl W, Shimizu A. S-homocysteinylation of transthyretin is detected in plasma and serum of humans with different types of hyperhomocysteinemia. Bichem Biophys Res Commun 2003;310:242-6 (Pubitemid 37168008)
29. Ogorzalek Loo RR, Yam L, Loo JA, Schumaker VN. Virtual two-dimensional gel electrophoresis of high-density lipoproteins. Electrophoresis 2004;25:2384-91 (Pubitemid 39136359)
30. Farwig NZ, Campbell AV, Macfarlane RD. Analysis of high-density lipoprotein apolipoproteins recovered from specific immobilized pH gradient gel pI domains by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Chem 2003;75:3823-30
31. Wang XL, Dudman NP, Wang J, Wilcken DE. Mechanisms responsible for increasing immunoreactivity of apolipoprotein A-I with storage: the role of oxidation. Clin Chem 1989;35:2082-6 (Pubitemid 19262630)